Atlas Trials

Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric Study

Clinical trial NCT06589895 · COMPLETED

Trial details

NCT number
NCT06589895
Sponsor
Centre Hospitalier Universitaire de Nīmes
Status
COMPLETED
Study type
OBSERVATIONAL
Inflammatory Bowel Diseases
Start date
2021-06-01
Primary completion
2024-05-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.